American Journal of Cardiology
Volume 102, Issue 10 , Pages 1418-1420 , 15 November 2008

The First Patient Clinically Diagnosed With Hypertrophic Cardiomyopathy

  • Barry J. Maron, MD

      Affiliations

    • Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    • Corresponding Author InformationCorresponding author: Tel: 612-863-3996; fax: 612-863-3875
    • ,
  • Robert O. Bonow, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Lisa Salberg

      Affiliations

    • Hypertrophic Cardiomyopathy Association, Hibernia, New Jersey
    • ,
  • William C. Roberts, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Dallas, Texas
    • ,
  • Eugene Braunwald, MD

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts

Received 18 July 2008 ,Revised 4 August 2008 ,Accepted 4 August 2008.

References 

  1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy (A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol. 2003;42:1687–1713
  2. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281:650–655
  3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  4. Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced ages. J Am Coll Cardiol. 2003;42:882–888
  5. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114::216–225
  6. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39:301–307
  7. Maron BJ, Spirito P, Shen W-K, Haas TS, Formisano F, Link MS, et al Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412
  8. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470–476
  9. Shirani J, Maron BJ, Cannon RO, Shahin S, Roberts WC. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol. 1993;72:434–440
  10. Morrow AG, Braunwald E. Functional aortic stenosis: a malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation. 1959;20:181–189
  11. Braunwald E, Lambrew GT, Morrow AG, Pierce GE, Rockoff SD, Ross J. Idiopathic hypertrophic subaortic stenosis (American Heart Association Monograph #10). Circulation. 1964;29&30(suppl):4–212
  12. Braunwald E, Morrow AG, Cornell WP, Aygen MM, Hilbish TF. Idiopathic hypertrophic subaortic stenosis: clinical, hemodynamic and angiographic manifestations. Am J Med. 1960;29:924–945
  13. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979;43:1086–1102

PII: S0002-9149(08)01404-5

doi: 10.1016/j.amjcard.2008.08.024

American Journal of Cardiology
Volume 102, Issue 10 , Pages 1418-1420 , 15 November 2008

Article Tools

* Image Usage & Resolution